Archive for December, 2019
Hospital pharmacies and pharmacy chains cooperate
Recently, the Medical Product Administration of Guizhou province issued the “Notification on Improving Pharmacy Chains Management in Guizhou Province.” The “Notification” indicated that pharmacy chains are encouraged to provide pharmaceutical services jointly with hospital pharmacies according to their own supply practice. Besides, online prescribing and pharmaceutical services should be promoted as well.
医院药房要与药店打通了
来源：新浪医药新闻 2019.12.27
近日，贵州省药监局发布了《关于进一步规范全省药品零售企业管理工作的通知》（以下简称《通知》）。《通知》提出，药品零售企业在不改变药品经营方式的前提下，鼓励为社区医疗机构提供药房药事服务；积极推进“互联网+远程药学服务”进行远程审方。[:]
97 negotiations targeted drugs will be published on the internet (National Negotiation)
On December 16th, the NHSA and the National Health Commission jointly issued the “Notification on Ensuring the Usage and Supply of Drugs that are Targeted in the National Negotiation.” The “Notification” stipulated that provincial healthcare security administrations should publish the 97 negotiations targeted drugs on their centralized procurement platform and their new reimbursement drug lists. Besides, healthcare departments should regulate the usage and supply of these drugs and instruct medical institutions to reserve and use them properly according to functions, clinical requirements, and healing effects.
两部门发文：97个国家谈判药品按时直接挂网
来源：医药网 2019.12.18
12月16日，国家医保局、国家卫健委联合发布《关于做好2019年国家医保谈判药品落地工作的通知》。《通知》要求，各省级医保部门应在规定时限内将97个谈判药品在省级药品集中采购平台上直接挂网，并保证新版目录及时落地。此外，各地医保和卫生部门应对谈判药品的配备及使用等方面提出具体要求，并指导各定点医疗机构根据功能定位、临床需求、和诊疗能力等即时配备、合理使用。
A national drug use supervision platform is launched
The National Health Commission announced that a national drug use supervision platform is launched, which can provide data to support healthcare administrations to supervise and analyse the drug use. 8840 medical institutions have registered on the platform.
国家药品使用监测平台上线运行 8000多家医院已登陆
来源：医药网 2019.12.11
国家卫健委统计信息中心今日发布消息，国家药品使用监测平台正式上线运行。目前，已有8840家医疗卫生机构完成系统登录。卫健委表示，“国家药品使用监测平台”将为各级卫生健康药政管理部门开展药品配备使用情况监测分析提供数据支撑。
Supervising the drug price and investigating the cost price
On December 6th, the National Medical Insurance Bureau issued the “Opinions on Supervising the Drug Price.” The “Opinion” indicated that a pricing system that depends on the market should be encouraged, and the centralised procurement with defined quantities, of which the drug price depends on the quantities and the bidding process combines with the procurement, should be further implemented. The “Opinion” also stipulated that a pre-warning system of abnormal drug price movements and an investigation system of the cost price of drugs should be established as well.
国家医保局发布文件：监管药品价格 调查成本
来源：医药网 2019.12.09
12月6日，国家医保局发布《关于做好当前药品价格管理工作的意见》（以下简称《意见》）。《意见》指出，坚持市场调节药品价格的总体方向；坚持“带量采购、量价挂钩、招采合一”的方针。《意见》要求，应建立价格供应异常变动监测预警机制，并完善药品价格成本调查工作机制。
Establishing a nationwide unified procurement platform of drugs
On November 29th, the National Health Commission issued the “Notification on Measures of Deepening the Reform of the Medical and Healthcare System depending on the Centralised Procurement and Use of Drugs.” The “Notification” emphasised that a nationwide unified procurement platform based on provincial centralised procurement platforms should be established, in which the drug codes and procurement standards should be unified so that the drug price can be linked together nationwide. In addition, corporate groups, integrated healthcare organisations, private medical institutions, and pharmacies are encouraged to implement centralised procurement to develop a pricing system that depends on the market. The “Notification” also stipulated that the medical insurance administrative agencies instead of hospitals should pay for the drugs to manufacturers and distributors directly.
医药行业变革：建设全国采购平台 全国价格联动
来源：医药网 2019.12.02
11月29日，国家卫健委体制改革司发布《国务院深化医药卫生改革领导小组印发关于以药品集中采购和使用为突破口进一步深化医药卫生体制改革若干政策措施的通知》。《通知》强调，应依托省级集中采购平台构建全国公共采购市场，统一编码、标准和功能规范，推进价格等相关信息互联互通，促进全国价格联动；鼓励探索集团采购、医联体采购等方式形成合理价格，鼓励非公立医疗机构、社会药店等积极参与，共同推动形成以市场为主导的药品价格形成机制；《通知》还要求，应由医保经办机构直接与生产或流通企业结算药品货款。